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Introduction: Bone marrow-derived mesenchymal stem cells (BM-MSCs) have been proposed as an ideal
autologous stem cell source for cell-based therapy for myocardial infarction (MI). However, decreased viability and
impaired function of aged MSCs hampered the therapeutic efficacy of engrafted MSCs, and the underlying
mechanisms remain unclarified. Here, we investigated the role of inositol phosphates 6 kinase (IP6Ks) inhibition on
the therapeutic efficacy of BM-MSCs and its underlying mechanism.
Methods: BM-MSCs isolated from young (8-week-old) or aged (18-month-old) donor male C57BL/6 mice, were
subjected to hypoxia and serum deprivation (H/SD) injury with or without administration of inositol phosphates 6
kinase (IP6Ks) inhibitor TNP (10 μM). MSC apoptosis induced by H/SD was determined by flow cytometry and
TUNEL assays. Protein expressions were evaluated by Western blot assay. Furthermore, the paracrine effects of MSCs
were measured by reverse transcriptase–polymerized chain reaction (RT-PCR) and enzyme-linked immunosorbent
assay (ELISA) analyses.
Results: Aged BM-MSCs exhibited more Inositol pyrophosphate 7 (IP7) production, compared with young BM-MSCs.
Meanwhile, the expression of phospho-Akt (Thr308) was significantly decreased in the aged MSCs, resulting in
enhanced Bad activation and decreased Bax/Bcl-2 ratio. Moreover, the apoptosis in aged BM-MSCs was increased,
compared with young BM-MSCs. Furthermore, TNP administration significantly inhibited IP7 production and increased
the phosphorylation of Akt under both normoxic and hypoxic conditions. Meanwhile, IP6Ks inhibition reduced
apoptotic index of aged MSCs, associated with decreased expressions of pro-apoptotic proteins Bax and Bad and
increased anti-apoptotic protein Bcl-2. The expressions of angiogenic factors, including VEGF, bFGF, IGF-1 and HGF,
were decreased in MSCs from aged mice. In addition, TNP administration enhanced the paracrine efficiency of aged
BM-MSCs under normoxic and hypoxic conditions.
Conclusions: This study demonstrates for the first time that IP6Ks and IP7 play critical role in the aging related
vulnerability to hypoxic injury and impaired paracrine efficiency of BM-MSCs, which is associated with impaired Akt
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Myocardial infarction (MI) leads to permanent loss of
cardiomyocytes which results in pathological remodel-
ing [1]. Even though current therapeutic strategies can
normalize coronary perfusion and, thus, ameliorate re-
modeling processes, the limited ability of the damaged
heart to regenerate leads to congestive heart failure,
which remains the leading cause of morbidity and mor-
tality worldwide [2,3]. Recently, stem cell therapy has
emerged as a promising method for treatment of ische-
mic heart disease [4]. Many clinical trials have demon-
strated the efficacy and safety of autologous stem cells
for MI treatment [5]. Among donor cell types, mesen-
chymal stem cells (MSCs) have been considered opti-
mal candidates for cardiac cell therapy because of their
plasticity and availability [6,7]. Indeed, intramyocardial
transplantation of MSCs has been confirmed effective
in treating ischemic heart disease [8,9]. However, pa-
tients suffering MI are mostly of advanced age [10]. Al-
though the influences of aging on the properties of
MSCs remain largely unexplored, aging may have sig-
nificant effects on final clinical outcomes [11]. Thus,
clarifying the effect of aging on MSCs and the under-
lying mechanisms are particularly crucial for autologous
cell therapy development.
Aging is a complicated pathophysiological process
accompanied by diminished activation of pro-survival
kinase Akt which is correlated with greater sensitivity
to hypoxic injury [12,13]. Therefore, optimizing approaches
to augment impaired Akt activation and enhanced aged
donor cell functional survival are crucial to optimizing
cell therapy for MI.
Inositol phosphates (IPs) are a diverse group of signal-
ing molecules that are widely distributed in mammals
[14]. Most studied is inositol 1,4,5-trisphosphate (IP3),
which regulates cellular calcium. 5-Diphosphoinositol
pentakisphosphate (5-[PP]-IP5 or IP7), yielded from in-
ositol hexakisphosphate (IP6) phosphorylated by inosi-
tol hexakisphosphate kinases (IP6Ks), is found to serve
multiple biological functions including apoptosis and
insulin secretion [15,16]. Recent studies indicate that
IP7 synthesized by IP6K appears to inhibit Akt [17].
Moreover, N6-(p-nitrobenzyl) purine (TNP), a purine
analogue, is identified as an inhibitor of IP6Ks in vitro
which inhibited inositol pyrophosphate 7 (InsP7) synthesis
without affecting the production of other inositol phos-
phates [18]. Therefore, TNP is a useful pharmacological
tool to further understand the role of InsP7 synthesis in
the aging process of MSCs. Accordingly, we hypothesized
that IP7 plays a critical role in impaired Akt activation
which contributes to the poor viability and function of
aged MSCs. Furthermore, age-related IP7 synthesis may
be a promising novel target for augmenting the MSC
therapeutic efficacy for MI.Methods
Animals
Young (8-week-old) and aged (18-month-old) male
C57BL/6 mice were used for the isolation of bone mar-
row mesenchymal stem cells (BM-MSCs) as described
previously [11]. All procedures were approved by the
Animal Care and Use Committee of the Fourth Military
Medical University (Approval ID: 12119) and were in
compliance with Guidelines for the Care and Use of
Laboratory Animals, as published by the National Acad-
emy Press.
Isolation, culture and characterization of mesenchymal
stem cells
BM-MSCs were isolated using a standard protocol as de-
scribed previously [7]. Briefly, femoral and tibia marrow
were isolated and flushed with phosphate-buffered saline
(PBS). The adherent MSC were propagated and main-
tained in high glucose (Dulbecco’s) modified Eagle’s
medium ((D)MEM) supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin/streptomycin medium.
Third-passage MSCs were used for experiments to avoid
contamination with other cell types.
MSCs were characterized by flow cytometry for surface
markers expression and in vitro differentiation as previously
reported [7]. In brief, after being incubated with monoclo-
nal phycoerythrin (PE)-conjugated antibodies against CD
markers (BD, San Jose, CA, USA) for one hour, BM-MSCs
isolated from young and aged mice were processed through
a FACS Caliper system (BD) according to the manufac-
turer’s protocol. For in vitro differentiation, BM-MSCs were
induced with adipogenic media (αMEM with 10% FCS,
1% antibiotics, 50 μM indomethacin (Sigma, Saint Louis,
Missouri, USA), 0.5 mM IBMX (Sigma) and 1 μM dexa-
methasone) and osteogenic medium (OM, 10% FBS,
0.1 μM dexamethasone, 10 mM β-glycerophosphate, and
0.2 mM ascorbic acid in α-MEM) for 21 days, which was
estimated by Oil red O and alizarin red S stain, respectively.
Hypoxia/serum deprivation injury
After IP6Ks inhibition with TNP (10 μM for two hours),
MSCs were stimulated with hypoxia/serum deprivation
(H/SD) injury as described previously [7]. Briefly, after be-
ing replaced in Hanks buffer, BM-MSCs were exposed to
hypoxia (94% N2–5% CO2–1% O2) in an anaerobic system
(Thermo Forma, Waltham, Massachusetts, USA) at 37°C
for six hours. In the control group, MSCs were maintained
at normoxia (95% air–5% CO2) for equivalent periods.
Inositol polyphosphates analysis
To test the concentration of IP7 in MSCs, we monitored
inositol polyphosphate levels by HPLC after labeling with
[3H]-inositol [16]. In brief, MSCs were seeded onto 24-
well plates at 1 × 106 cells/ml. After washing with inositol
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[3H]inositol in (D)MEM supplemented with 10% FBS for
72 hours. Then, cells were scrapped after being lysed with
0.5 M trichloroacetic acid. The supernatant was collected
and prepared for HPLC analysis. The inositol phosphates
were eluted by HPLC with an optimal gradient.
Flow cytometry assay for MSCs apoptosis
MSC apoptosis induced by H/SD was determined by flow
cytometry assay using an Annexin V-FITC/PI Kit (Merck,
Whitehouse Station, New Jersey, USA) according to the
manufacturer’s instructions [7]. Briefly, MSCs were harvested
with 0.025% trypsin (Sigma Aldrich, Saint Louis, MO, USA)
and incubated with 10 μl of Annexin V solution and 5 μl
propidium iodide (PI) for 30 minutes at room temperature.
The apoptosis of MSCs was analyzed on a FACSC-LSR
(Becton, Dickinson and Company, San Jose, CA, USA).
Terminal deoxynucleotidy1 transferase-mediated dUTP
nick end-labeling (TUNEL) assay
To confirm the apoptosis of MSCs, in situ detection
of DNA fragmentation was performed using the TUNEL
assay with an assay kit (In Situ Cell Death Detection Kit;
Roche Diagnostics, Basel, Switzerland) according to the
manufacturer’s instructions [19]. Briefly, after H/SD injury,
MSCs were incubated with terminal deoxynucleotidy1
transferase (TdT) and fluorescein-labeled dUTP for 45 mi-
nutes at 37°C followed by 4,6-diamidino-2-phenylindole
(DAPI) for the identification of the nucleus. The percent-
age of apoptotic cells was termed the apoptotic index. All
of these assays were performed in a blinded manner.
Caspase-3 activity measurement
Caspase-3 activity was measured with the Caspase-3
Assay kit (Clontech, Mountain View, California, USA)
according to the manufacturer’s instructions. Briefly,
substrate cleavage was monitored fluorometrically with
a SpectraMax Gemini spectrophotometer (Molecular
Devices, Sunnyvale, California, USA) with excitation and
emission wavelengths of 350 nm and 450 nm.
Western blot assay
The expressions of Akt, Bax, Bcl-2 and Bad in MSCs
were assessed by Western blotting following standard
protocol [20]. Briefly, MSCs were lysed at 4°C in buffer
containing Tris-buffered saline, 0.1% Triton X-100 (1 mM,
Sigma), 4% glycerol, ethylenediaminetetraacetic acid (EDTA)
(1 mM, Sigma) and protease inhibitor phenylmethane-
sulfonyl fluoride (PMSF) (1 mM, Roche Molecular Bio-
chemicals). The insoluble material was removed by
centrifugation at 6,000 × g, and the supernatants were
diluted in SDS sample buffer. Equal amounts of protein
(50 μg/lane) were separated by electrophoresis on 12%
SDS-PAGE gels for 90 minutes at 120 V and sequentiallyelectrophoretically transferred to nitrocellulose (NC)
membranes. After blocking, NC membranes were sub-
jected to immunoblotting with primary antibodies against
Akt (1:500), p-Akt (1:500), p-Bad (1:500), Bad (1:500),
Bcl-2 (1:500), Bax (1:500) and β-actin (1:2000) over
night at 4°C. After incubation with the appropriate sec-
ondary antibody conjugated with horseradish peroxidase,
blot bands were visualized with an enhanced chemilumines-
cene system (Amersham Bioscience, Fairfield, Connecticut,
USA). Densitometric analysis of Western blots was per-
formed using VisionWorks LS, version 6.7.1.
Evaluation of VEGF, bFGF, IGF-1 and HGF
After H/SD injury, MSCs were harvested and analyzed by
RT-PCR for vascular endothelial growth factor (VEGF),
basic fibroblast growth factor (bFGF), insulin-like growth
factor-1 (IGF-1) and hepatocyte growth factor (HGF). RT-
PCR conditions were standard for all samples. Briefly, total
cellular RNA was extracted by RNeasy (QIAGEN, Hilden,
Germany) and was reverse transcribed using the Tran-
scriptor First Strand cDNA Synthesis Kit (Roche Molecu-
lar Biochemicals, Mannheim, Germany) according to the
manufacturer’s instructions. The samples were subjected
to 40 cycles of amplification at 95°C for 15 seconds
followed by 64°C for 20 seconds and 72°C for 25 seconds
by using the specific primers. The results of the assays
were normalized to the level of GAPDH.
The concentrations of VEGF, bFGF, IGF-1 and HGF
secreted by MSCs were also assessed by ELISA (Life
Technologies, Carlsbad, California, USA) according to the
manufacturer’s instructions as previously described [20].
All samples and standards were measured in duplicate.
Statistical analysis
The results are presented as mean ± standard error of the
mean (SEM). Statistics were calculated using Prism 5.0
(GraphPad Software Inc, San Diego, CA, USA). Statistical
comparisons for different groups were performed using
either the Student’s t test or one-way analysis of vari-




The multipotency of MSCs from both young and aged
mice was confirmed by adipogenic and osteogenic differ-
entiation assays. After being induced with adipogenic
media for 21 days, approximately 80% of MSCs had an
adipocyte phenotype which was assessed by Oil red O
staining. To examine the osteoblastogenic differentiation
ability of MSC, cells were incubated in osteoblastogenic
medium and stained by alizarin red S, demonstrating
calcium deposits (Figure 1A). Flow cytometry results re-
vealed that MSCs from both young and older donor
Figure 1 Characterization of mesenchymal stem cells from both aged and young mice. (A) MSCs from both young and aged donor mice
display fibroblast-like morphology. The pluripotency of MSCs from both young and aged mice was confirmed by adipogenic and osteogenic
differentiation assays which were detected by Oil red O staining and alizarin red S staining, respectively. (B) Flow cytometry results show that
MSCs from both young and aged donor mice were uniformly negative for CD34 and CD45, and positive for CD44 and CD90 (n = 5). MSCs,
mesenchymal stem cells.
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CD29, while they were negative for the haematopoietic
markers CD31, CD34 and leukocyte common antigen
CD45 (Figure 1B).
Aged mesenchymal stem cells secreted more IP7
To evaluate the synthesis of IP7in MSCs, we monitored
inositol polyphosphate levels by HPLC (Figure 2A,B).
There was no difference in the IP6 expression in both
groups. However, in comparison to young MSCs, in-
creased IP7 synthesis was observed in aged MSCs under
normoxic condition (15.83 ± 1.09% of IP6 versus 7.45 ±0.73% of IP6, P <0.05). Notably, H/SD injury further pro-
moted IP7 synthesis in aged MSCs (29.16 ± 1.04% of IP6
versus 16.25 ± 0.66% of IP6 in young MSCs, P <0.05).
Aging was associated with decreased Akt activation
Akt is an upstream regulator of the Bcl-2 family which
regulates cell apoptosis and proliferation. To determine
the effect of aging on the activation of Akt signaling, phos-
phorylated Akt in MSCs of young and aged mice was de-
termined by Western blotting. As shown in Figure 2C-D,
the expression of phospho-Akt was significantly decreased
in the aged MSCs, indicating impaired Akt activation in
Figure 2 IP7 synthesis and Akt activation in young and aged MSCs after hypoxia and serum deprivation (H/SD) injury. (A) HPLC profiles
of inositol phosphates isolated from young and aged MSCs under normoxic or hypoxic conditions. (B) Quantitative analysis of IP7 production as
a percentage of IP6 in MSCs. (C) Representative Western blots of p-Akt (T308), Akt, p-Bad, Bad, Bcl-2 and Bax expression in young and aged MSCs
after H/SD. Semiquantitative analysis of p-Akt (D), p-Bad (E), Bcl-2 and Bax (F). Data are expressed as mean ± SEM. n = 5, *P <0.05, CPM, counts per
minute. H/SD, hypoxia and serum deprivation; IP7, 5-diphosphoinositol pentakisphosphate; MSCs, mesenchymal stem cells; SEM, standard error of
the mean.
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aging-associated hyp-phosphorylation of Akt in MSCs.
Compared with young MSCs, enhanced expression of the
pro-apoptotic protein Bad and decreased Bax/Bcl-2 ratio
were also observed in aged MSCs (Figure 2C,E,F).
Aging increased the apoptosis of MSCs induced by
H/SD injury
To analyze the effect of aging on the apoptosis of MSCs,
TUNEL assay and flow cytometry assays were performed.As representative photomicrographs show in Figure 3A,
TUNEL-positive MSCs were observed more frequently
in aged MSCs. Quantitative analyses revealed that the
apoptosis index in aged MSCs was 14.03% ± 1.5% under
normoxic conditions and 26.27% ± 1.4% under hypoxic
conditions, significantly higher than that in young MSCs
(6.33% ± 0.5% under normoxic conditions, 15.01% ± 0.6%
under hypoxic conditions, Figure 3C). Representative flow
cytometry results in Figure 3B revealed significantly en-
hanced apoptosis of aged MSCs (10.66 ± 0.55% versus
Figure 3 Aging increased the apoptosis of MSCs induced by H/SD injury. (A) Representative immunofluorescence images of apoptosis
(TUNEL, green fluorescent) and DAPI (blue fluorescence) in young and aged MSCs under hypoxic or normoxic conditions (Scale bars: 50 μm).
(B) Apoptosis was also analyzed by flow cytometry after staining with Annexin V and propidium iodide (PI). (C) Quantification of the apoptotic
MSCs is presented as the percentage of apoptotic cells. (D) Quantification of the FACS analysis. Viable cells: Annexin V−/PI−; early apoptosis:
Annexin V+/PI−; late apoptosis: V+/PI+; necrotic: V−/PI+. (E): Caspase-3 activity of MSCs in all groups. Data expressed as mean ± SEM. n = 5,
*P <0.05, #P <0.05 versus young + H/SD. DAPI, 4,6-diamidino-2-phenylindole; FACS, fluorescence-activated cell sorting; H/SD, hypoxia and serum
deprivation; MSC, mesenchymal stem cells; SEM, standard error of the mean; TUNEL, terminal- deoxynucleotidyl transferase mediated nick end
labeling.
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further increased the apoptosis of MSCs induced by
hypoxia (24.32 ± 0.65% in aged MSCs versus 13.24 ±
0.51% in young MSCs, P <0.05, Figure 3D). Concur-
rently, aging also significantly increased the caspase-3
enzymatic activity in MSCs under normoxic or hypoxic
conditions (P <0.05, Figure 3E). These data suggest that
aging increases the apoptosis of MSCs under both nor-
moxic and hypoxic conditions.IP7 hampered Akt phosphorylation in aged MSCs
After being incubated with TNP, a selective inhibitor of
IP6Ks, IP7 production in aged MSCs was significantly
hampered both under normoxic and hypoxic conditions
(Figure 4A,B). Notably, inhibition of IP6Ks further
promoted the phosphorylation of Akt in aged MSCs
(Figure 4C). Moreover, the decreased expressions of
the pro-apoptosis proteins Bax and Bad were observed
in aged MSCs with TNP pretreatment. Furthermore,
Figure 4 TNP decreased IP7 production and enhanced Akt activation in aged MSCs. (A) HPLC profiles of inositol phosphates isolated from
aged MSCs with or without the IP6Ks inhibitor TNP. (B) Quantitative analysis of IP7 production as a percentage of IP6 in MSCs. Representative
Western blots and semiquantitative analysis of the expressions of p-Akt (T308) (C), p-Bad (D), Bcl-2 and Bax (E) in aged MSCs after H/SD with or
without TNP incubation. Data are expressed as mean ± SEM. n = 5, *P <0.05. CPM, counts per minute. H/SD, hypoxia and serum deprivation; IP6Ks,
inositol hexakis phosphate kinases; IP7, 5-diphosphoinositol pentakisphosphate; MSCs, mesenchymal stem cells; SEM, standard error of the mean;
TNP, N6-(p-nitrobenzyl) purine.
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protein Bcl-2 (Figure 4D,E). These data indicate that
increased IP7 synthesis hampers Akt activation in aged
MSCs.
IP6Ks inhibition prevented apoptosis of aged MSCs
Representative TUNEL and flow cytometry results in
Figure 5A,B demonstrated that H/SD significantly in-
duced apoptosis of aged MSCs (36.73 ± 1.62% versus
16.67 ± 0.75% under normal conditions, P <0.05), while
TNP pretreatment significantly decreased the percentage
of apoptotic aged MSCs under normoxic and hypoxic
conditions (11.53 ± 0.87% in normoxia and 25.63 ± 0.68%
in H/SD, P <0.05).
TNP enhanced paracrine efficiency of aged MSCs
It has been shown that MSCs contribute to cardiac repair
and regeneration at least in part by a paracrine mechan-
ism. Therefore, we performed RT-PCR and ELISA assays
to evaluate the effect of aging on cytokine secretion in
MSCs. We observed that young MSCs expressed VEGF
((0.49 ± 0.03) × 103 pg/ml), bFGF (18.03 ± 1.57 pg/ml),IGF-1(37.21 ± 4.23 pg/ml) and HGF (21.28 ± 2.43 pg/ml)
under normal conditions. After six hours H/SD injury,
VEGF ((1.35 ± 0.08) × 103 pg/ml) and bFGF (32.34 ±
2.15 pg/ml) secreted by young MSCs were significantly
increased. Furthermore, RT–PCR (Figure 6A) and ELISA
(Figure 6B-E) revealed that the expression (for both
mRNA and protein levels) of growth factors, including
VEGF, bFGF, IGF-1 and HGF, secreted by aged MSCs
was significantly decreased in comparison to young
MSCs, under both normoxic and hypoxic conditions.
However, IP6KS inhibition with TNP enhanced the
paracrine efficiency of aged MSCs under normoxic and
hypoxic conditions.
Discussion
Autologous bone marrow mesenchymal stem cells
have been considered an ideal cell source for MI therapy
[21]. A multitude of animal studies have demonstrated
that MSCs could restore cardiac function [7]. However,
intracoronary transplantation of autologous bone marrow
stem cells led to slightly long-term myocardial functional
improvement in our previous clinical study for STEMI
Figure 5 TNP decreased apoptosis of aged MSCs. (A) Representative confocal microscopic images of TUNEL stains for the hypoxia-induced
apoptosis in aged MSCs with or without the IP6Ks inhibitor TNP. (B) Apoptosis was also analyzed by flow cytometry after staining with Annexin V
and PI. (C) Quantification of the TUNEL assay is presented as the percentage of apoptotic cells. (D) Quantification of the FACS analysis. Viable cells:
Annexin V−/PI−; early apoptosis: Annexin V+/PI−; late apoptosis: V+/PI+; necrotic: V−/PI+. (E) Caspase-3 activity of MSCs in all groups. Data are
expressed as mean ± SEM. n = 5, *P <0.05, # P <0.05 versus H/SD. FACS, fluorescence-activated cell sorting; H/SD, hypoxia and serum deprivation;
IP6Ks, inositol hexakis phosphate kinases; MSCs, mesenchymal stem cells; SEM, standard error of the mean; TNP, N6-(p-nitrobenzyl) purine; TUNEL,
terminal- deoxynucleotidyl transferase mediated nick end labeling.
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interplay between engrafted cells, cytokines and ischemic
microenvironment may ultimately influence the clinical
outcomes, BM-MSCs obtained from elderly patients seem
less therapeutically efficacious for ischemic heart diseases
[11]. In the present study, we demonstrated for the first
time that MSCs from aged mice secreted significantly more
IP7 compared to young mice, which leads to impaired Akt
activation and paracrine effects. Furthermore, IP7 synthesis
was also associated with the deterioration and impairment
of aged MSCs in hypoxic conditions, indicating that age-
related IP7 may play a critical role in the therapeutic effi-
cacy of MSC for MI.Aging is a complicated pathophysiological process which
negatively impacts tissue repair and healing [22]. It has
been reported that age influences the proliferation poten-
tial of MSCs [11]. Furthermore, the function and thera-
peutic potential of MSCs generally decline with age [10].
In the present study, we found that BM-MSCs from aged
mice exhibit increased apoptosis compared with those
from young mice. To further explore the influence of
aging on the apoptosis of MSCs in an ischemic environ-
ment, we subjected cultured cells to hypoxia and serum
deprivation conditions. Zhu et al. reported that the
early apoptosis in MSCs induced by hypoxia and serum
deprivation peaked at six hours [23]. Therefore, we also
Figure 6 TNP enhanced paracrine efficiency of aged MSCs. (A) Representative RT-PCR results of the mRNA levels of VEGF, bFGF, IGF-1 and
HGF in young MSCs, aged MSCs and even aged MSCs with TNP. The protein expressions of VEGF (B), bFGF (C), IGF-1 (D) and HGF (E) were
measured by ELISA assays. Data are expressed as mean ± SEM. n = 5, *P <0.05. bFGF, basic fibroblast growth factor; HGF, hepatocyte growth factor;
IGF-1, insulin-like growth factor-1; MSCs, mesenchymal stem cells; SEM, standard error of the mean; TNP, N6-(p-nitrobenzyl) purine; VEGF, vascular
endothelial growth factor.
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effects of aging appear to increase the apoptosis induced
by H/SD injury, indicating that aging is associated with in-
creased vulnerability to hypoxic injury in MSCs. Previous
studies have demonstrated that hypoxia inhibits mito-
chondrial respiration and decreases mitochondrial DNA
(mtDNA) genomes numbers, which in turn influence the
mitochondrial permeability [24]. Loss of mitochondrial
membrane potential results in the release of cytochrome
c, which has been recognized as a regulator in apoptosis
[25]. Apoptosis is a complex process which is modulated
by extrinsic and intrinsic pathways [26]. Bcl-2 family pro-
teins are the chief regulators which conduct the intrinsicpathways of apoptosis [27]. The family of BCL2 proteins,
which consists of both anti-apoptosis proteins and
pro-apoptosis proteins, is divided into three subgroups
depending on the number of BH domains [28]. The
pro-survival proteins, such as Bcl-2 and Bcl-xL, share
four BH domains, whereas the pro-apoptotic proteins
Bax and Bak contain three BH domains [29,30]. In the
present study, we observed that the expressions of pro-
apoptosis proteins, such as Bad and Bax, were significantly
increased in aged MSCs under both normoxic and hyp-
oxic conditions. Meanwhile, aging also decreased the ex-
pression of the anti-apoptosis protein Bcl-2. Furthermore,
the inhibition of IP6Ks was associated with decreased
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Bcl-2 ratio. Taken together, these data indicate that aging
regulates IP7 synthesis and the expression of BCL2 pro-
teins which, in turn, mediate the apoptosis of MSCs.
Akt (PKB), a serine/threonine protein kinase, plays a
central role in regulating cell survival, metabolism and
protein synthesis via the phosphorylation of its numerous
substrates. Given the multifunctional roles ascribed to
Akt, it is likely that aging-related disorders are associated
with Akt dysregulation. Watanabe et al. [31] demonstrated
that impaired PI3K/Akt activation directly contributes to
the effect of aging on pancreatic acinar cell proliferation.
Similarly, Satyanarayana et al. [32,33] have revealed that
aging-induced muscle atrophy is associated with differ-
ences in the regulation of Akt and mTOR. Furthermore, it
has been reported that reduced activation of extracellular
signal-regulated kinase (ERK) and Akt kinase contributes
to lower survival of aged hepatocytes which are more sen-
sitive to H2O2-induced apoptosis [34,35]. In the present
study, we observed impaired activation of Akt in the
MSCs. Furthermore, H/SD injury further reduced the
aging-associated hyp-phosphorylation of Akt. These data
indicate that the increased vulnerability of MSCs to hyp-
oxic injury with aging is due to impaired Akt activation.
Therefore, the restoration of Akt kinase activity has been
considered as an attractive therapeutic target to protect
aged MSCs from hypoxic injury. Various strategies have
been adopted to enhance Akt activation in MSCs. Mangi
et al. [36] genetically modified MSCs with Akt using retro-
viruses and found that the engineered MSCs (Akt-MSCs)
were more resistant to hypoxic injury. Moreover, Haider
et al. [30] revealed that MSCs with overexpression of
IGF-1 display both increased Akt activation and en-
hanced viability. However, gene modifications might re-
sult in insertional mutagenesis. In addition, prolonged
activation of constitutively Akt gene may increase the
risk of tumorigenesis which hampers genetically engi-
neered cells for clinical therapy [37]. An alternative
strategy to gene delivery is temporary activation of Akt
with pharmaceutical pretreatment.
Inositol polyphosphates, a diverse group of signaling
molecules, are produced through the action of sequential
phosphorylations by inositol polyphosphate kinases
(IPKs) from IP3 [37]. IP3, which regulates intracellular
calcium release, can be sequentially phosphorylated to
generate inositol hexakisphosphate (IP6) and 5-diphospho-
inositolpentakisphosphate (5-PP-IP5, or IP7). Although the
physiological functions of IPs remain poorly characterized,
IP7 appears to inhibit Akt signaling and to modulate cell
apoptosis [17].
To explore the relationship between aging and IP7 level,
we measured inositol phosphates in MSCs from both aged
and young donor mice. The level of IP7 was elevated in
aged mice, resulting in impaired Akt activation, which isconsistent with the results of Chakraborty et al. [17]. Fur-
thermore, hypoxic injury resulted in an enhancement in
the age-dependent increase of IP7, indicating that in-
creased IP7 with aging interferes with Akt activation. In
addition, the rise in IP7 levels is substantially reduced by
the IP6Ks inhibitor TNP, which was associated with de-
creased apoptosis and increased paracrine effect of MSCs,
indicating that IP7 may be involved in the hypoxic injury
of MSCs. Taken together, our results indicate that aging
increases IP7 synthesis, which inhibits the activation of
Akt signaling, leading to impairment after hypoxic injury.
MSCs are capable of secreting a broad variety of bio-
active factors, such as VEGF, bFGF, HGF, and IGF-1,
which enhance neovascularization and inhibit host cardio-
myocyte death [7]. Therefore, a growing body of evidence
supports the hypothesis that MSCs provide a beneficial
effect through paracrine activity for clinical autologous
cell therapy for MI. However, the effect of aging on the
xparacrine activity of MSCs still remains unclear. We
pursued our investigation further to elucidate aging
dependent growth factor expression in MSCs. Previous
studies have revealed that hypoxic stimulation could in-
crease cytokine secretion in MSCs [7,11]. In our study,
the gene expression of VEGF and bFGF in MSCs was
significantly increased under hypoxic stress. Interest-
ingly, no effect of hypoxia on the expressions of IGF-1
and HGF was observed. However, significant reductions
in the secretion of angiogenic factors were observed in
aged MSCs, especially under hypoxic conditions. These
results are supported by the gene expression profiles, as
determined by RT-PCR analyses. Certainly, our data
suggest that aging negatively modulates the paracrine
activity of MSCs. Furthermore, the inhibition of IP6Ks
with TNP restored the decreased paracrine efficiency of
aged MSCs under normoxic and hypoxic conditions.
Therefore, our data indicate that aging impaired para-
crine efficiency of MSCs at least in part via IP6Ks and
IP7, which may be promising novel targets for augment-
ing the therapeutic efficacy of aged MSCs.
Although the H/SD model used in the present study is
considered useful to exclude the influence of neural and
humoral factors in vivo, this model is limited as an arti-
ficial experimental model that cannot fully simulate the
in vivo ischemic and inflammatory environment. More-
over, the physiological functions of IP7 have not been
extensively clarified. Therefore, further studies defining
the exact mechanism(s) are needed to thoroughly under-
stand the aging process of MSCs.
Conclusions
In conclusion, the current study demonstrates that aging
increases the vulnerability of MSCs to hypoxic injury
with impaired paracrine efficiency. Moreover, increased
IP7 formation by IP6Ks, which inhibits Akt activation,
Zhang et al. Stem Cell Research & Therapy 2014, 5:33 Page 11 of 12
http://stemcellres.com/content/5/2/33may directly contribute to the aging-related injury of
MSCs. Furthermore, inhibition of IP6Ks has the poten-
tial to protect the aged MSCs via activation of Akt
signaling. Overall, our results indicate that IP6Ks and
IP7 may be promising novel modification targets for op-
timizing autologous MSCs therapy for MI.
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